Literature DB >> 23414081

Changes in screening behaviors and attitudes toward screening from pre-test genetic counseling to post-disclosure in Lynch syndrome families.

A M Burton-Chase1, S R Hovick, S K Peterson, S K Marani, S W Vernon, C I Amos, M L Frazier, P M Lynch, E R Gritz.   

Abstract

The purpose of this study was to examine colonoscopy adherence and attitudes toward colorectal cancer (CRC) screening in individuals who underwent Lynch syndrome genetic counseling and testing. We evaluated changes in colonoscopy adherence and CRC screening attitudes in 78 cancer-unaffected relatives of Lynch syndrome mutation carriers before pre-test genetic counseling (baseline) and at 6 and 12 months post-disclosure of test results (52 mutation negative and 26 mutation positive). While both groups were similar at baseline, at 12 months post-disclosure, a greater number of mutation-positive individuals had had a colonoscopy compared with mutation-negative individuals. From baseline to 12 months post-disclosure, the mutation-positive group demonstrated an increase in mean scores on measures of colonoscopy commitment, self-efficacy, and perceived benefits of CRC screening, and a decrease in mean scores for perceived barriers to CRC screening. Mean scores on colonoscopy commitment decreased from baseline to 6 months in the mutation-negative group. To conclude, adherence to risk-appropriate guidelines for CRC surveillance improved after genetic counseling and testing for Lynch syndrome. Mutation-positive individuals reported increasingly positive attitudes toward CRC screening after receiving genetic test results, potentially reinforcing longer term colonoscopy adherence.
© 2013 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2013        PMID: 23414081      PMCID: PMC3833250          DOI: 10.1111/cge.12091

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  36 in total

Review 1.  The future of genetic counselling: an international perspective.

Authors:  B Bowles Biesecker; T M Marteau
Journal:  Nat Genet       Date:  1999-06       Impact factor: 38.330

2.  Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome.

Authors:  Elena M Stoffel; Rowena C Mercado; Wendy Kohlmann; Beth Ford; Shilpa Grover; Peggy Conrad; Amie Blanco; Kristen M Shannon; Mark Powell; Daniel C Chung; Jonathan Terdiman; Stephen B Gruber; Sapna Syngal
Journal:  Am J Gastroenterol       Date:  2010-03-30       Impact factor: 10.864

3.  Compliance and Satisfaction with Long-Term Surveillance in Finnish HNPCC Families.

Authors:  Kirsi Pylvänäinen; Matti Kairaluoma; Jukka-Pekka Mecklin
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

4.  Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer.

Authors:  Ellen R Gritz; Susan K Peterson; Sally W Vernon; Salma K Marani; Walter F Baile; Beatty G Watts; Christopher I Amos; Marsha L Frazier; Patrick M Lynch
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

5.  Genetic counseling outcomes: perceived risk and distress after counseling for hereditary colorectal cancer.

Authors:  Ann-Marie Codori; Tracy Waldeck; Gloria M Petersen; Diana Miglioretti; Jill D Trimbath; Miriam A Tillery
Journal:  J Genet Couns       Date:  2005-04       Impact factor: 2.537

Review 6.  Psychological impact of genetic testing for cancer susceptibility: an update of the literature.

Authors:  Bettina Meiser
Journal:  Psychooncology       Date:  2005-12       Impact factor: 3.894

7.  Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer.

Authors:  S W Vernon; E R Gritz; S K Peterson; C I Amos; C A Perz; W F Baile; P M Lynch
Journal:  Health Psychol       Date:  1997-01       Impact factor: 4.267

8.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.

Authors:  R Fishel; M K Lescoe; M R Rao; N G Copeland; N A Jenkins; J Garber; M Kane; R Kolodner
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

9.  Mutations of GTBP in genetically unstable cells.

Authors:  N Papadopoulos; N C Nicolaides; B Liu; R Parsons; C Lengauer; F Palombo; A D'Arrigo; S Markowitz; J K Willson; K W Kinzler
Journal:  Science       Date:  1995-06-30       Impact factor: 47.728

10.  Mutations of two PMS homologues in hereditary nonpolyposis colon cancer.

Authors:  N C Nicolaides; N Papadopoulos; B Liu; Y F Wei; K C Carter; S M Ruben; C A Rosen; W A Haseltine; R D Fleischmann; C M Fraser
Journal:  Nature       Date:  1994-09-01       Impact factor: 49.962

View more
  12 in total

1.  Screening adherence and cancer risk perceptions in colorectal cancer survivors with Lynch-like syndrome.

Authors:  L H Katz; A M Burton-Chase; S Advani; B Fellman; K M Polivka; Y Yuan; P M Lynch; S K Peterson
Journal:  Clin Genet       Date:  2015-09-14       Impact factor: 4.438

2.  Worldwide Practice Patterns in Lynch Syndrome Diagnosis and Management, Based on Data From the International Mismatch Repair Consortium.

Authors:  Jennifer Y Pan; Robert W Haile; Allyson Templeton; Finlay Macrae; FeiFei Qin; Vandana Sundaram; Uri Ladabaum
Journal:  Clin Gastroenterol Hepatol       Date:  2018-04-24       Impact factor: 11.382

3.  Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.

Authors:  Terri Febbraro; Katina Robison; Jennifer Scalia Wilbur; Jessica Laprise; Amy Bregar; Vrishali Lopes; Robert Legare; Ashley Stuckey
Journal:  Gynecol Oncol       Date:  2015-04-28       Impact factor: 5.482

Review 4.  Communication and technology in genetic counseling for familial cancer.

Authors:  H T Lynch; C Snyder; M Stacey; B Olson; S K Peterson; S Buxbaum; T Shaw; P M Lynch
Journal:  Clin Genet       Date:  2013-12-20       Impact factor: 4.438

5.  Long-term psychosocial and behavioral adjustment in individuals receiving genetic test results in Lynch syndrome.

Authors:  M J Esplen; J Wong; M Aronson; K Butler; H Rothenmund; K Semotiuk; L Madlensky; C Way; E Dicks; J Green; S Gallinger
Journal:  Clin Genet       Date:  2014-10-28       Impact factor: 4.438

6.  The Impact of Receiving Predictive Genetic Information about Lynch Syndrome on Individual Colonoscopy and Smoking Behaviors.

Authors:  Joanne Soo-Min Kim; Peter C Coyte; Michelle Cotterchio; Louise A Keogh; Louisa B Flander; Clara Gaff; Audrey Laporte
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-08-15       Impact factor: 4.254

7.  Universal Versus Targeted Screening for Lynch Syndrome: Comparing Ascertainment and Costs Based on Clinical Experience.

Authors:  Mujde Z Erten; Luca P Fernandez; Hank K Ng; Wendy C McKinnon; Brandie Heald; Christopher J Koliba; Marc S Greenblatt
Journal:  Dig Dis Sci       Date:  2016-07-06       Impact factor: 3.199

8.  Patient Perspectives Regarding Genetic Testing for Familial Hypercholesterolemia.

Authors:  Miles Marchand; Victoria Chen; Mark Trinder; Lubomira Cermakova; Liam R Brunham
Journal:  CJC Open       Date:  2021-04-08

9.  How does genetic risk information for Lynch syndrome translate to risk management behaviours?

Authors:  Emma Steel; Andrew Robbins; Mark Jenkins; Louisa Flander; Clara Gaff; Louise Keogh
Journal:  Hered Cancer Clin Pract       Date:  2017-01-05       Impact factor: 2.857

10.  Uptake of cancer risk management strategies among women who undergo cascade genetic testing for breast cancer susceptibility genes.

Authors:  Sukh Makhnoon; Grace Tran; Brooke Levin; Kristin D Mattie; Brian Dreyer; Robert J Volk; Generosa Grana; Banu K Arun; Susan K Peterson
Journal:  Cancer       Date:  2021-06-22       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.